Ergoteles’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-42,389
| Closed | -$1.72M | – | 645 |
|
|
2023
Q2 | $1.72M | Buy |
42,389
+26,945
| +174% | +$1.1M | 0.08% | 311 |
|
|
2023
Q1 | $748K | Sell |
15,444
-26,899
| -64% | -$1.3M | 0.03% | 602 |
|
|
2022
Q4 | $1.62M | Buy |
42,343
+10,572
| +33% | +$404K | 0.06% | 326 |
|
|
2022
Q3 | $1.6M | Buy |
31,771
+6,930
| +28% | +$348K | 0.06% | 338 |
|
|
2022
Q2 | $995K | Buy |
24,841
+5,201
| +26% | +$208K | 0.03% | 544 |
|
|
2022
Q1 | $733K | Sell |
19,640
-9,620
| -33% | -$359K | 0.03% | 531 |
|
|
2021
Q4 | $1.17M | Buy |
+29,260
| New | +$1.17M | 0.05% | 378 |
|